Phurimin 37.5 mg (Phentermine Hydrochloride)

Adult dose

Adults: Take 37.5 mg of phentermine hydrochloride once daily before breakfast or 1–2 hours after breakfast. Use the lowest effective dose, adjusting it individually to achieve an adequate response. For some patients, 18.75 mg once daily may be appropriate; in some cases, 18.75 mg twice daily may be preferable. Avoid taking this medicine late at night, as it may cause insomnia. This medicine should be administered for a short period (up to 4 weeks). However, to reduce inappropriate use and the risks associated with this medicine, treatment may be continued if the patient achieves satisfactory weight loss within the first 4 weeks (a weight loss of at least 1.8 kg, or weight loss considered satisfactory by both the physician and the patient).

This medication should not be used in combination with other appetite suppressants. Taking it with other drugs for weight loss may not be safe. It is recommended to use this medication alone and for a short duration when treating exogenous obesity. If symptoms such as difficulty breathing, chest pain, fainting, or leg swelling occur, consult a doctor immediately, and discontinue use of the medication if these symptoms appear. There may be a risk related to heart valve disease, so it should not be taken in high doses for a long time or combined with other appetite suppressants. Patients with cardiovascular disease, hypertension, hyperthyroidism, glaucoma, psychological instability, or a history of substance abuse should not take this medication. Pregnant women or women who may become pregnant, children under 16 years of age, and individuals with certain genetic lactose-related disorders should not take this medication. Patients with diabetes or mild hypertension require special caution when taking this medication. In case of overdose, severe symptoms such as anxiety, coma, seizures, blood pressure abnormalities, and vomiting may occur; hence, it is essential to adhere to the prescribed dosage. Be cautious about engaging in hazardous activities such as driving or operating machinery while taking this medication, and it is advisable not to combine it with alcohol. Pregnant or breastfeeding women should only take this medication after carefully considering its risks and benefits. This medication is classified as a narcotic and must be used strictly under a doctor’s prescription and guidance. Abuse may lead to mental dependence and severe side effects. Keep this medication out of reach of children.

Primary pulmonary hypertension, regurgitant heart valve disease, palpitations, tachycardia, hypertension, overstimulation, anxiety, dizziness, insomnia, malaise, euphoria, tremors, headache, psychotic seizures, thirst, unpleasant taste, diarrhea, constipation, other gastrointestinal disturbances, urticaria, erectile dysfunction, changes in sexual drive, anxiety, coma, paradoxical reactions, respiratory stimulation, confusion, hallucinations, aggression, panic state, convulsions in the event of fatal poisoning, coma, death, arrhythmia, hypertension, hypotension, circulatory shock, nausea, vomiting, abdominal pain, severe dermatitis, hypersensitivity, hyperfunction, changes in personality, schizophrenia-like psychosis

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication for a longer period.

Appearance

White butterfly tie-shaped tablet

Package unit

30 tablets/bottle, 100 tablets/bottle